Gilead Sciences · 10 hours ago
Director, Public Affairs, Digital Platforms & AI Enablement
San Francisco Bay Area
Full-time
Hybrid
Director/Executive
$210K/yr - $272K/yr
8+ years expGilead Sciences is dedicated to creating a healthier world by tackling major diseases and developing life-changing therapies. They are seeking a Director of Public Affairs, Digital Platforms & AI Enablement to lead the strategy and evolution of digital platforms that enhance Gilead's communications and public affairs initiatives.
BiopharmaBiotechnologyHealth CareManufacturingPharmaceutical
Responsibilities
Own and continuously evolve the Public Affairs digital platform roadmap—spanning CMS, DAM, social publishing, analytics, workflow, search, and internal digital signage—grounded in business outcomes and measurable KPIs
Establish and chair governance for platform usage, data standards, integrations, and compliance (privacy, accessibility, cybersecurity)
Lead responsible AI adoption across content lifecycle (briefing, authoring, tagging, QA, localization, distribution, and reporting), including policy, guardrails, and change management
Partner with IT, Cybersecurity, Privacy, and Enterprise Architecture to ensure platforms are secure, compliant, observable, and cost‑efficient (SLA/SLO/SLI management)
Oversee platform performance, integrations, upgrades, migrations, and vendor relationships; run RFPs, negotiate SOWs, and manage TCO/budgets
Define enterprise metadata, taxonomy, and tagging standards (including schema.org/OGP), and ensure consistent implementation across channels
Enable accurate measurement and reporting through event schema design, consented data flows, and integration across CDP/BI tools
Act as a strategic advisor on digital technology trends (headless, composable, AI), conducting quarterly architecture reviews and proofs of concept
Qualification
Required
Bachelor's degree + 8+ years in digital platforms, marketing technology, or digital transformation; 3+ years leading cross‑functional platform teams or programs
Hands‑on leadership across at least two enterprise CMS/DAM stacks and two analytics/BI stacks; proven record launching or migrating enterprise sites or social programs
Experience implementing AI or automation in regulated environments with documented guardrails and measurable impact
Exceptional stakeholder management, vendor management, and strategic thinking; able to translate business goals into technical roadmaps and backlog
Preferred
Advanced degree + pharmaceutical/biotech or other regulated industry experience
Global operations exposure (multi‑region hosting, localization, accessibility, privacy)
Enterprise/headless content & asset ops across AEM, Sitecore; and AEM Assets, Bynder, Aprimo, Brandfolder
Orchestrate social publishing/listening/care (Sprinklr, Sprout, Hootsuite; Brandwatch, Talkwalker) and end‑to‑end data stack—analytics, tagging, CDP, BI, experimentation (GA4/Adobe; GTM/Tealium/Segment/AudienceStream; BigQuery/Looker/Power BI/Tableau
Familiarity with MLR workflows and Veeva PromoMats
Relevant certifications (e.g., Adobe AEM/Analytics, GA4, Optimizely, Salesforce Marketing Cloud, Microsoft Azure Fundamentals/AI‑900, OneTrust, CIPP/CIPM, AWS/GCP fundamentals)
Benefits
Discretionary annual bonus
Discretionary stock-based long-term incentives (eligibility may vary based on role)
Paid time off
Company-sponsored medical, dental, vision, and life insurance plans
Company
Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
10001+ employees
H1B Sponsorship
Gilead Sciences has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (269)
2024 (241)
2023 (222)
2022 (208)
2021 (235)
2020 (187)
Funding
Current Stage
Public CompanyTotal Funding
$4.41BKey Investors
Abingworth
2024-11-13Post Ipo Debt· $3.5M
2024-02-29Post Ipo Equity· $210M
2023-09-07Post Ipo Debt· $2B
Leadership Team
Keeley Wettan
Senior Vice President, Legal
Patrick Loerch
Senior Vice President, Clinical Data Science
Recent News
2026-01-23
GlobeNewswire
2026-01-22
Company data provided by crunchbase